ArticleACS omega2023
Ru-Doped Co
Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 25 citations in OpenAlex.
- Review
- Atomically Ru-Doped CoSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
- Single-Atom Ruthenium Sites on Cobalt-Titanium Surfaces for Efficient and Selective Chloride Electrolysis.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Graphene nanosheets decorated with heterostructured ruthenium sulfide as catalyst for enhanced hydrogen evolution reaction.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The electrochemical chlorine evolution reaction (CER) is one of the most important electrochemical reactions. Typically, iridium (Ir)- or ruthenium (Ru)-based mixed metal oxides have been used as electrocatalysts for the CER due to their high activities and durabilities. However, the scarcity of Ir and Ru has indicated the need to develop alternative earth-abundant transition-metal-based CER catalysts. In this study, we report a Co
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.